Search

Displaying results 9331 - 9340 of 10000 in total
  1. Drug

    Abrilumab

    go.drugbank.com/drugs/DB15076
    Investigational

    Abrilumab is under investigation in clinical trial NCT01290042 (Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AMG 181.).

  2. Drug

    Acebilustat

    go.drugbank.com/drugs/DB15385
    Investigational

    Acebilustat is under investigation in clinical trial NCT01748838 (Phase 1 Study Assessing the Safety and Tolerability of CTX-4430).

  3. Drug

    Coprelotamab

    go.drugbank.com/drugs/DB16380
    Investigational

    Coprelotamab is under investigation in clinical trial NCT04170595 (Clinical Study of Recombinant Anti-her2 Humanized Monoclonal Antibody for Injection).

  4. Drug

    Toralizumab

    go.drugbank.com/drugs/DB16384
    Investigational

    Toralizumab is under investigation in clinical trial NCT03605927 (CD40-L Blockade for Prevention of Acute Graft-versus-host Disease).

  5. Drug

    Dasiprotimut-T

    go.drugbank.com/drugs/DB17287
    Experimental

    [A254701] It has been investigated in clinical trials.

  6. Drug

    Rivabazumab pegol

    go.drugbank.com/drugs/DB17788
    Investigational

    Rivabazumab pegol is being investigated as a treatment of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis.[A259457]

    Synonyms: KB001-A (AN ANTI-PCRV PEGYLATED MONOCLONAL ANTIBODY FRAGMENT TO THE TYPE III SECRETION SYSTEM OF PSEUDOMONAS AERUGINOSA)
  7. Drug

    Clesacostat

    go.drugbank.com/drugs/DB18956
    Investigational

    Clesacostat is under investigation in clinical trial NCT04321031 (Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)).

  8. Drug

    Dimepheptanol

    go.drugbank.com/drugs/DB19094
    Investigational

    Dimepheptanol is under investigation in clinical trial NCT00218127 (Treatment of Opioid/heroin Dependence: Comparison of Three Medication Dosing Regimens).

  9. Drug

    KYV-101

    go.drugbank.com/drugs/DB23168
    Investigational

    KYV-101 is under investigation in clinical trial NCT06152172 (CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101).

  10. Drug

    Nifekalant

    go.drugbank.com/drugs/DB16008
    Investigational

    Nifekalant is under investigation in clinical trial NCT03855826 (Evaluation of the Efficacy and Safety of Nifekalant Hydrochloride (NIF) Injection).